Indonesia Minister of Health Aims to Scale SPHERES Initiative Nationwide Following High-Level Visit
PURBALINGGA, March 10, 2026 – During a high-profile visit to the SPHERES project site in Purbalingga, Central Java, Indonesia’s Minister of Health, Budi Gunadi Sadikin, lauded the project’s progress and set an ambitious target for its national expansion. […]
From Factory Worker to Infectious Diseases Scientist: The Story of OUCRU Indonesia’s Suwarti
Suwarti is a scientist at OUCRU Indonesia who specialises in clinical laboratory research. Her work involves detecting diseases, tracking how pathogens evolve, and studying how the human body responds to […]
OUCRU & the Hospital for Tropical Diseases: 35 years of partnership.
From our earliest malaria trials in 1991 to today’s shared work on many infectious diseases, we mark 35 years of partnership with the Hospital for Tropical Diseases (HTD), HCMC. This year, Oxford University Clinical Research […]
First MODRA cohort graduates
The first cohort of the MORU–OUCRU Discovery Research Academy, MODRA, has officially graduated following a final four-day workshop held in December 2025 in Sanur, Bali. The workshop marked the conclusion […]
No Survival Benefit from High-Dose Rifampicin in Tuberculous Meningitis, Major Global Trial Finds
A major international clinical trial, known as the HARVEST trial, has found that giving a higher dose of rifampicin does not improve survival in adults with tuberculous meningitis, the most […]
Study Finds COVID-19 Vaccine Boosters Still Protect Vulnerable Indonesians Well Into the Post-Pandemic Period
COVID-19 vaccine booster shots made from the original strain of the virus still save lives among vulnerable Indonesians, but provide limited protection for the wider public, according to a new […]
WHO Releases New Global Antimicrobial Resistance Surveillance Report: Highlights and OUCRU’s Contribution
WHO released its latest Global Antimicrobial Resistance and Use Surveillance (GLASS) Report last week, with new findings on antimicrobial resistance (AMR) around the world. The 2025 report draws on data […]
Indonesia to Host First Dual-Species Malaria Vaccination Trial
OUCRU Indonesia is preparing a Phase 2 clinical trial of a malaria vaccination designed to protect against the two most widespread malaria parasites, Plasmodium falciparum and Plasmodium vivax. The trial, […]
Chloroquine and Hydroxychloroquine Show Moderate Effect in Preventing COVID-19, New Large Clinical Trial Shows
12 December 2024 – The world’s largest study on the use of hydroxychloroquine (HCQ) and chloroquine (CQ) to prevent COVID-19 has published results showing moderate protection against the virus. The […]
OUCRU góp phần xác định ưu tiên nghiên cứu toàn cầu về kháng thuốc kháng sinh
Các nhà nghiên cứu OUCRU từ Indonesia, Nepal và Việt Nam đã góp phần xây dựng danh sách các ưu tiên nghiên cứu về kháng thuốc (AMR) mới được Tổ […]
Nghiên cứu mới: Quản lý kháng sinh tại bệnh viện Indonesia còn nhiều hạn chế
Ngày 19 tháng 11 năm 2024 – Một nghiên cứu quốc gia do Khoa Y, Đại học Indonesia (FMUI) và OUCRU Indonesia thực hiện đã phát hiện ra rằng, trong […]
Wellcome Trust Delegates Visit OUCRU Indonesia
On 14 October 2024, a delegation from Wellcome visited OUCRU Indonesia to deepen their understanding of the unit’s research, learn about its collaborations with various partners, and gain insights into […]
OUCRU and Universitas Indonesia Complete Historic Malaria Vaccine Trial
In a major achievement, the Faculty of Medicine Universitas Indonesia (FMUI) and OUCRU Indonesia have completed a phase 2 clinical trial for two new malaria vaccines developed by Sanaria Inc. […]
Nghiên cứu của OUCRU Indonesia nhận giải thưởng tại Hội nghị Khoa học về Đại dịch Quốc tế 2024
Tiến sỹ Edward Sutanto MPH, OUCRU Indonesia, đã được trao giải “Trình bày Poster Khoa học Xuất Sắc Nhất” trong hạng mục Vắc xin và Miễn dịch học tại Hội […]
12 Years of Collaboration: Wellcome Trust, OUCRU, and Universitas Indonesia Celebrate Milestone Partnership
OUCRU, Wellcome Trust, and Faculty of Medicine of Universitas Indonesia Celebrate 12 years of partnership in a ceremony in January 2024.